The diagnosis and management of insomnia

New England Journal of Medicine

Volumn 322, Issue 4, 1990, Pages 239-248

  Oates, John A ^a   Wood, Alastair J J ^a   Gillin, J Christian ^a   Byerley, William F ^b  

^a NAVAL MEDICAL CENTER SAN DIEGO   (United States)

^b UNIVERSITY OF UTAH HEALTH SCIENCES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84993875894     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM199001253220406     Document Type: Review

References (106)

1. Association of Sleep Disorders Centers, Association for the Psychophysiological Study of Sleep. Diagnostic classification of sleep and arousal disorders, 1979. 1st ed. Sleep 1979; 2: 1–154.
2. American Psychiatric Association. Diagnostic and statistical manual of mental disorders: (DSM-III-R) 3rd ed. rev. Washington, D.C.: American Psychiatric Press, 1987.
3. Institute of Medicine. Sleeping pills, insomnia, and medical practice: report of a study. Washington, D.C.: National Academy of Sciences, 1979. (Institute of Medicine publication no. 79–04.)
4. Drugs and insomnia: the use of medications to promote sleep. JAMA 1984; 251: 2410–4.
5. Kales A, Kales JD. Evaluation and treatment of insomnia. New York: Oxford University Press, 1984.
6. Mellinger GD, Balter MB, Uhlenhuth EH. Insomnia and its treatment: prevalence and correlates. Arch Gen Psychiatry 1985; 42: 225–32.
7. Clift AD, ed. Sleep disturbance and hypnotic drug dependence. Amsterdam: Excerpta Medica, 1975:155–77.
8. Coleman RM, Roffwarg HP, Kennedy SJ, et al. Sleep–wake disorders based on a polysomnographic diagnosis: a national cooperative study. JAMA 1982; 247: 997–1003.
9. Daan S, Beersma DG, Borbely AA. Timing of human sleep: recovery process gated by a circadian pacemaker. Am J Physiol 1984; 246: R161–R183.
10. Drennan M, Kripke DF, Gillin JC. Bright light can delay human temperature rhythm independent of sleep. Am J Physiol 1989; 257: R136–R141.
11. Winget CM, DeRoshia CW, Markley CL, Holley DC. A review of human physiological and performance changes associated with desynchronosis of biological rhythms. Aviat Space Environ Med 1984; 55: 1085–96.
12. Czeisler CA, Kronauer RE, Allan JS, et al. Bright light induction of strong (type 0) resetting of the human circadian pacemaker. Science 1989; 244: 1328–33.
13. Czeisler CA, Moore-Ede MC, Coleman RM. Rotating shift work schedules that disrupt sleep are improved by applying circadian principles. Science 1982; 217: 460–3.
14. Zorick FJ, Roth T, Hartze KM, Piccione PM, Stepanski EJ. Evaluation and diagnosis of persistent insomnia. Am J Psychiatry 1981; 138: 769–73.
15. Edinger JD, Hoelscher TJ, Webb MD, Marsh GR, Radtke RA, Erwin CW. Polysomnographic assessment of DIMS: empirical evaluation of its diagnostic value. Sleep 1989; 12: 315–22.
16. Hauri PJ. A cluster analysis of insomnia. Sleep 1983; 6: 326–38.
17. Jacobs EA, Reynolds CF III, Kupfer DJ, Lovin PA, Ehrenpreis AB. The role of polysomnography in the differential diagnosis of chronic insomnia. Am J Psychiatry 1988; 145: 346–9.
18. Gillin JC, Mendelson WB. Sleeping pills: for whom? When? How long? In: Palmer GC, ed. Neuropharmacology of central nervous system and behavioral disorders. New York: Academic Press, 1980:285–316.
19. Spielman AJ. Assessment of insomnia. Clin Psychol Rev 1986; 6: 11–25.
20. Kales A, Bixler EO, Tan T-L, Scharf MB, Kales JD. Chronic hypnotic-drug use: ineffectiveness, drug-withdrawal insomnia, and dependence. JAMA 1974; 227: 513–7.
21. Kales A, Soldatos CR, Bixler EO, Kales JD. Rebound insomnia and rebound anxiety: a review. Pharmacology 1983; 26: 121–37.
22. Gillin JC, Spinweber CL, Johnson LC. Rebound insomnia: a critical review. J Clin Psychopharmacol 1989; 9: 161–72.
23. Greenblatt DJ, Harmatz JS, Zinny MA, Shader RI. Effect of gradual withdrawal on the rebound sleep disorder after discontinuation of triazolam. N Engl J Med 1987; 317: 722–8.
24. Adams K, Oswald I. Can a rapidly-eliminated hypnotic cause daytime anxiety? Pharmacopsychiatry 1989; 22: 115–9.
25. Miller MM, Seidel WF, van den Hoed J, Greenblatt J, Dement WC. Comparative hypnotic effects of flurazepam, triazolam, and placebo: a long-term simultaneous nighttime and daytime study. J Clin Psychopharmacol 1984; 4: 2–13.
26. Adams K, Oswald I, Shapiro C. Effects of loprazolam and of triazolam on sleep and overnight urinary cortisol. Psychopharmacol (Berlin) 1984; 82: 389–94.
27. Mamelak M, Csima A, Price V. A comparative 25-night sleep laboratory study on the effects of quazepam and triazolam on chronic insomniacs. J Clin Pharmacol 1984; 24: 65–75.
28. Hackett PH, Roach RC, Harrison GL, Schoene RB, Mills WJ Jr. Respiratory stimulants and sleep periodic breathing at high altitude: almitrine versus acetazolamide. Am Rev Respir Dis 1987; 135: 896–8.
29. Kales JD, Kales A, Bixler EO, et al. Biopsychobehavioral correlates of insomnia, V: clinical characteristics and behavioral correlates. Am J Psychiatry 1984; 141: 1371–6.
30. Ware JC. Tricyclic antidepressants in the treatment of insomnia. J Clin Psychiatry 1983; 44: 25–8.
31. Hench PK, Mitler MM. Fibromyalgia. I. Review of a common rheumatologic syndrome. Postgrad Med 1986; 80: 47–56.
32. Prinz PN, Vitaliano PP. Vitiello MV, et al. Sleep EEG and mental function changes in senile dementia of the Alzheimer's type. Neurobiol Aging 1982; 3: 361–70.
33. Fischer-Perroudon C, Mouret J, Jouvet M. Sur un cas d'agrypnie (4 mois sans sommeil) au cours d'une maladie de Morvan: effet favorable du 5-hydroxytryptophane. Electroencephalogr Clin Neurophysiol 1974; 36: 1–18.
34. Lugaresi E, Medori R, Montagna P, et al. Fatal familial insomnia and dysautonomia with selective degeneration of thalamic nuclei. N Engl J Med 1986; 315: 997–1003.
35. Weitzman ED, Czeisler CA, Coleman RM, et al. Delayed sleep phase syndrome: a chronobiological disorder with sleep-onset insomnia. Arch Gen Psychiatry 1981; 38: 737–46.
36. Lingjaerde O, Bratlid T, Hansen T. Insomnia during the “dark period” in northern Norway: an explorative, controlled trial with light treatment. Acta Psychiatr Scand 1985; 71: 506–12.
37. Gordon NP, Cleary PD, Parker CE, Czeisler CA. The prevalence and health impact of shiftwork. Am J Public Health 1986; 76: 1225–8.
38. Walsh TD. Antidepressants in chronic pain. Clin Neuropharmacol 1983; 6: 271–95.
39. Kales A, Bixler EO, Soldatos CR, Vela Bueno A, Caldwell AB, Cadieux RJ. Biopsychobehavioral correlates of insomnia, part I. Role of sleep apnea and nocturnal myoclonus. Psychosomatics 1982; 23: 589–600.
40. Ancoli-Israel S, Kripke DF, Mason W, Kaplan OJ. Sleep apnea and periodic movements in an aging sample. J Gerontol 1985; 40: 419–25.
41. Clough C. Restless legs syndrome. Br Med J 1987; 294: 262–3.
42. Oswald I. Sudden bodily jerks on falling asleep. Brain 1959; 82: 92–103.
43. Hauri P, Sataia MJ. Nonpharmacologic treatment of sleep disorders. In: Hales RE, Frances AJ, eds. Psychiatry update: American Psychiatric Association annual review. Vol. 4. Washington, D.C.: American Psychiatric Press, 1985:361–78.
44. Spielman AJ, Saskin P, Thorpy MJ. Treatment of chronic insomnia by restriction of time in bed. Sleep 1987; 10: 45–56.
45. Greenblatt DJ, Divoll M, Abernethy DR, Ochs HR, Schader RI. Benzodiazepine kinetics: implication for therapeutics and pharmacogeriatrics. Drug Metab Rev 1983; 14: 251–92.
46. Miller LG, Greenblatt DJ, Abernethy DR, et al. Kinetics, brain uptake, and receptor binding characteristics of flurazepam and its metabolites. Psychopharmacology (Berlin) 1988; 94: 386–91.
47. Greenblatt DJ, Divoll M, Harmatz JS, McLaughlin DS, Shader RI. Kinetics and clinical effects of flurazepam in young and elderly noninsomniacs. Clin Pharmacol Ther 1981; 30: 475–86.
48. Bliwise D, Seidel W, Karacan I, et al. Daytime sleepiness as a criterion in hypnotic medication trials: comparison of triazolam and flurazepam. Sleep 1983; 6: 156–63.
49. Oswald I, Adam K, Borrow S, Idzikowski C. The effects of two hypnotics on sleep, subjective feelings and skilled performance. In: Passouant P, Oswald I, eds. Pharmacology of the states of alertness: proceedings of the satellite symposium of the 7th International Congress of Pharmacology, Montpellier, 24–25 July 1978. Oxford: Pergamon Press, 1979:51–63.
50. Johnson LC, Chernik DA. Sedative-hypnotics and human performance. Psychopharmacology (Berlin) 1982; 76: 101–13.
51. Salkind MR, Silverstone T. A clinical and psychometric evaluation of flurazepam. Br J Clin Pharmacol 1975; 2: 223–6.
52. Johnson LC, Chernik DA, eds. Effects of flurazepam and midazolam on sleep and next-day performance in chronic insomniacs: report of a multi-center study. J Clin Psychopharmacol 1988 (in press).
53. Greenblatt DJ, Allen MD, Shader RI. Toxicity of high-dose flurazepam in the elderly. Clin Pharmacol Ther 1977; 21: 355–61.
54. Marttila JK, Hammel RJ, Alexander B, Zustiak R. Potential untoward effects of long-term use of flurazepam in geriatric patients. J Am Pharm Assoc 1977; 17: 692–5.
55. Woods JH, Katz JL, Winger G. Abuse liability of benzodiazepines. Pharmacol Rev 1987; 39: 251–413.
56. Browne JL, Hauge KJ. A review of alprazolam withdrawal. Drug Intell Clin Pharm 1986; 20: 837–41.
57. Busto U, Sellers EM, Naranjo CA, Cappell H. Sanchez-Craig M, Sykora K. Withdrawal reaction after long-term therapeutic use of benzodiazepines. N Engl J Med 1986; 315: 854–9.
58. Morris HH III, Estes ML. Traveler's amnesia: transient global amnesia secondary to triazolam. JAMA 1987; 258: 945–6.
59. Bixler EO, Kales A, Brubaker BH, Kales JD. Adverse reactions to benzodiazepine hypnotics: spontaneous reporting system. Pharmacology 1987; 35: 286–300.
60. Lister RG. The amnesic action of benzodiazepines in man. Neurosci Bio-behav Rev 1985; 9: 87–94.
61. Spinweber CL, Johnson LC. Effects of triazolam (0.5 mg) on sleep, performance, memory, and arousal threshold. Psychopharmacology (Berlin) 1982; 76: 5–12.
62. Sunter JP, Bal TS, Cowan WK. Three cases of fatal triazolam poisoning. Br Med J 1988; 297: 719.
63. O'Dowd JJ, Spragg PP, Routledge PA. Fatal triazolam poisoning. Br Med J 1988; 297: 1048.
64. Greenblatt DJ, Shader RI, Divoll M, Harmatz JS. Adverse reactions to triazolam, flurazepam, and placebo in controlled clinical trials. J Clin Psychiatry 1984; 45: 192–5.
65. Kales A, Bixler EO, Vela-Bueno A, Solidatos CR, Niklaus DE, Manfredi RL. Comparison of short and long half-life benzodiazepine hypnotics: triazolam and oxazepam. Clin Pharmacol Ther 1986; 40: 378–86.
66. Oswald I. Triazolam syndrome 10 years on. Lancet 1989; 2: 451–2.
67. Seyffart G. Chloral hydrate and related drugs. In: Haddad LM, Winchester JF, eds. Clinical management of poisoning and drug overdose. Philadelphia: W.B. Saunders, 1983:527–31.
68. Rickels K, Morris RJ, Newman H, Rosenfeld H, Schiller H, Weinstock R. Diphenhydramine in insomniac family practice patients: a double-blind study. J Clin Pharmacol 1983; 23: 235–42.
69. Rickels K, Ginsberg J, Morris RJ, et al. Doxylamine succinate in insomniac family practice patients: a double-blind study. Curr Ther Res 1984; 35: 532–40.
70. Paton DM, Webster DR. Clinical pharmacokinetics of H1-receptor antagonists (the antihistamines). Clin Pharmacokinet 1985; 10: 477–97.
71. Friedman H, Greenblatt DJ. The pharmacokinetics of doxylamine: use of automated gas chromatography with nitrogen-phosphorus detection. J Clin Pharmacol 1985; 25: 448–51.
72. Schneider-Helmert D, Spinweber CL. Evaluation of L-tryptophan for treatment of insomnia: a review. Psychopharmacology (Berlin) 1986; 89: 1–7.
73. Steiner W, Fontaine R. Toxic reactions following the combined administration of fluoxetine and L-tryptophan: five case reports. Biol Psychiatry 1986; 21: 1067–71.
74. Levy AB, Bucher P, Votolato N. Myoclonus, hyperreflexia, and diaphoresis in patients on phenelzine-tryptophan combination treatment. Can J Psychiatry 1985; 30: 434–6.
75. Mendelson WB, Weingartner H, Greenblatt DJ, Garnett D, Gillin JC. A clinical study of flurazepam. Sleep 1982; 5: 350–60.
76. Dement WC, Carskadon MA, Mitler MM, Phillips RL, Zarcone VP. Prolonged use of flurazepam: a sleep laboratory study. Behav Med 1978; 5: 25–31.
77. Kales A, Bixler EO, Soldatos CR, Vela-Bueno A, Jacoby J, Kales JD. Quazepam and flurazepam: long-term use and extended withdrawal. Clin Pharmacol Ther 1982; 32: 781–8.
78. Roehrs T, Zorick F, Kaffeman M, Sicklesteel J, Roth T. Flurazepam for short-term treatment of complaints of insomnia. J Clin Pharmacol 1982; 22: 290–6.
79. Adam K, Oswald I. Effects of lormetazepam and of flurazepam on sleep. Br J Clin Pharmacol 1984; 17: 531–8.
80. Bixler EO, Kales A, Soldatos CR, Scharf MB, Kales JD. Effectiveness of temazepam with short-, intermediate-, and long-term use: sleep laboratory evaluation. J Clin Pharmacol 1978; 18: 110–8.
81. Miller MM, Carskadon MA, Phillips RL, et al. Hypnotic efficacy of temazepam: a long-term sleep laboratory evaluation. Br J Clin Pharmacol 1979; 8: 63S–68S.
82. Roehrs T, Lamphere J, Paxton C, Wittig R, Zorick F, Roth T. Temazepam's efficacy in patients with sleep onset insomnia. Br J Clin Pharmacol 1984; 17: 691–6.
83. Kales A, Bixler EO, Soldatos CR, Vela-Bueno A, Jacoby JA, Kales JD. Quazepam and temazepam: effects of short- and intermediate-term use and withdrawal. Clin Pharmacol Ther 1986; 39: 345–52.
84. Roth T, Kramer M, Lutz T. The effects of triazolam (.25 mg) on the sleep of insomnia subjects. Drugs Exp Clin Res 1977; 1: 279–85.
85. Bonnet MH. Effect of sleep disruption on sleep, performance, and mood. Sleep 1985; 8: 11–9.
86. Mamelak M, Adele C, Buck L, Price V. A comparative study of the effects of brotizolam and flurazepam on sleep and performance in the elderly. J Clin Psychopharmacol 1989; 9: 260–7.
87. Oswald I, French C, Adam K, Bilham J. Benzodiazepine hypnotics remain effective for 24 weeks. Br Med J 1982; 284: 860–3.
88. Swift CG, Swift MR, Hamley J, Stevenson IH, Crooks J. Side-effect “tolerance” in elderly long-term recipients of benzodiazepine hypnotics. Age aging 1984; 13: 335–43.
89. Clift AD. Factors leading to dependence on hypnotic drugs. Br Med J 1972; 3: 614–7.
90. Ray WA. Griffin MR, Schaffner W, Baugh DK, Melton LJ III. Psychotropic drug use and the risk of hip fracture. N Engl J Med 1987; 316: 363–9.
91. Johnson LC, Spinweber CL, Webb SC Muzet AG. Dose level effects of triazolam on sleep and response to a smoke detector alarm. Psychopharmacology (Berlin) 1987; 91: 397–402.
92. Seidel WF, Cohen SA, Bliwise NG, Roth T, Dement WC. Dose-related effects of triazolam and flurazepam on a circadian rhythm insomnia. Clin Pharmacol Ther 1986; 40: 314–20.
93. Bonnet MH, Dexter JR. Gillin JC, et al. The use of triazolam in phase-advanced sleep. Neuropsychopharmacology 1988; 1: 225–34.
94. Penetar DM, Belenky G, Garrigan JJ, Redmond DP. Triazolam impairs learning and fails to improve sleep in a long-range aerial deployment. Aviat Space Environ Med 1989; 60: 594–8.
95. Nicholson AN. Long-range air capability and the South Atlantic Campaign. Aviat Space Environ Med 1984; 55: 269–70.
96. Spinweber CL, Webb SC, Gillin JC. Jet lag in military operations: field trial of L-tryptophan in reducing sleep-loss effects. Report no. 86–15. San Diego: Naval Health Research Center, 1986.
97. Klink M, Quan SF. Prevalence of reported sleep disturbances in a general adult population and their relationship to obstructive airways diseases. Chest 1987; 91: 540–6.
98. Dement WC. Miles LE, Carskadon MA. “White paper” on sleep and aging. J Am Geriatr Soc 1982; 30: 25–50.
99. Morgan K. Sleep and aging: a research-based guide to sleep in later life. Baltimore: Johns Hopkins University Press, 1987.
100. Reynolds CV III, Coble PA, Black RS, Holzer B, Carroll R, Kupfer DJ. Sleep disturbances in a series of elderly patients: polysomnographic findings. J Am Geriatr Soc 1980; 28: 164–70.
101. Puder R, Lacks P. Bertelson AD, Storandt M. Short-term stimulus control treatment of insomnia in older adults. Behav Ther 1983; 14: 424–9.
102. Bayer AJ, Pathy MS. Requests for hypnotic drugs and placebo response in elderly hospital inpatients. Postgrad Med J 1985; 61: 317–20.
103. Beers M, Avorn J, Soumerai SB, Everitt DE, Sherman DS, Salem S. Psychoactive medication use in intermediate-care facility residents. JAMA 1988; 260: 3016–20.
104. Sanford JR. Tolerance of debility in elderly dependents by supporters at home: its significance for hospital practice. Br Med J 1975; 3: 471–3.
105. Ancoli-Israel S, Parker L, Sinaee R, Fell RL, Kripke DF. Sleep fragmentation in patients from a nursing home. J Gerontol 1989; 44: M18–M21.
106. Helms PM. Efficacy of antipsychotics in the treatment of the behavioral complications of dementia: a review of the literature. J Am Geriatr Soc 1985; 33: 206–9.